Global and United States Heart Failure Drugs Market Insights, Forecast to 2027

Global and United States Heart Failure Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Heart Failure Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Heart Failure Drugs Market Size Growth Rate by Type
1.2.2 ACEI
1.2.3 Angiotensin II Receptor Blockers
1.2.4 ARNIs
1.2.5 Beta Blockers
1.2.6 Aldosterone Antagonists
1.2.7 Diuretics
1.3 Market by Application
1.3.1 Global Heart Failure Drugs Market Size Growth Rate by Application
1.3.2 Reduced Ejection Fraction
1.3.3 Preserved Ejection Fraction
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Heart Failure Drugs Market Size, Estimates and Forecasts
2.1.1 Global Heart Failure Drugs Revenue 2016-2027
2.1.2 Global Heart Failure Drugs Sales 2016-2027
2.2 Global Heart Failure Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Heart Failure Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Heart Failure Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Heart Failure Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Heart Failure Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Heart Failure Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Heart Failure Drugs Revenue Forecast by Region (2022-2027)
3 Global Heart Failure Drugs Competitor Landscape by Players
3.1 Global Top Heart Failure Drugs Manufacturers by Sales
3.1.1 Global Heart Failure Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Heart Failure Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Heart Failure Drugs Manufacturers by Revenue
3.2.1 Key Heart Failure Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Heart Failure Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Heart Failure Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Heart Failure Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Heart Failure Drugs Revenue in 2020
3.2.6 Global Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Heart Failure Drugs Price by Manufacturers
3.4 Global Heart Failure Drugs Manufacturing Base Distribution, Product Types
3.4.1 Heart Failure Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Heart Failure Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Heart Failure Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Heart Failure Drugs Market Size by Type (2016-2021)
4.1.1 Global Heart Failure Drugs Sales by Type (2016-2021)
4.1.2 Global Heart Failure Drugs Revenue by Type (2016-2021)
4.1.3 Heart Failure Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Heart Failure Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Heart Failure Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Heart Failure Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Heart Failure Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Heart Failure Drugs Market Size by Application (2016-2021)
5.1.1 Global Heart Failure Drugs Sales by Application (2016-2021)
5.1.2 Global Heart Failure Drugs Revenue by Application (2016-2021)
5.1.3 Heart Failure Drugs Price by Application (2016-2021)
5.2 Heart Failure Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Heart Failure Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Heart Failure Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Heart Failure Drugs Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Heart Failure Drugs Market Size YoY Growth 2016-2027
6.1.1 United States Heart Failure Drugs Sales YoY Growth 2016-2027
6.1.2 United States Heart Failure Drugs Revenue YoY Growth 2016-2027
6.1.3 United States Heart Failure Drugs Market Share in Global Market 2016-2027
6.2 United States Heart Failure Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Heart Failure Drugs Players by Sales (2016-2021)
6.2.2 United States Top Heart Failure Drugs Players by Revenue (2016-2021)
6.3 United States Heart Failure Drugs Historic Market Review by Type (2016-2021)
6.3.1 United States Heart Failure Drugs Sales Market Share by Type (2016-2021)
6.3.2 United States Heart Failure Drugs Revenue Market Share by Type (2016-2021)
6.3.3 United States Heart Failure Drugs Price by Type (2016-2021)
6.4 United States Heart Failure Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Heart Failure Drugs Sales Forecast by Type (2022-2027)
6.4.2 United States Heart Failure Drugs Revenue Forecast by Type (2022-2027)
6.4.3 United States Heart Failure Drugs Price Forecast by Type (2022-2027)
6.5 United States Heart Failure Drugs Historic Market Review by Application (2016-2021)
6.5.1 United States Heart Failure Drugs Sales Market Share by Application (2016-2021)
6.5.2 United States Heart Failure Drugs Revenue Market Share by Application (2016-2021)
6.5.3 United States Heart Failure Drugs Price by Application (2016-2021)
6.6 United States Heart Failure Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Heart Failure Drugs Sales Forecast by Application (2022-2027)
6.6.2 United States Heart Failure Drugs Revenue Forecast by Application (2022-2027)
6.6.3 United States Heart Failure Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Heart Failure Drugs Market Size YoY Growth 2016-2027
7.2 North America Heart Failure Drugs Market Facts & Figures by Country
7.2.1 North America Heart Failure Drugs Sales by Country (2016-2021)
7.2.2 North America Heart Failure Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Heart Failure Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Heart Failure Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Heart Failure Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Heart Failure Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Heart Failure Drugs Market Size YoY Growth 2016-2027
9.2 Europe Heart Failure Drugs Market Facts & Figures by Country
9.2.1 Europe Heart Failure Drugs Sales by Country (2016-2021)
9.2.2 Europe Heart Failure Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Heart Failure Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Heart Failure Drugs Market Facts & Figures by Country
10.2.1 Latin America Heart Failure Drugs Sales by Country (2016-2021)
10.2.2 Latin America Heart Failure Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Heart Failure Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Heart Failure Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Heart Failure Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Heart Failure Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Description and Business Overview
12.1.3 Novartis Heart Failure Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Heart Failure Drugs Products Offered
12.1.5 Novartis Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Description and Business Overview
12.2.3 Pfizer Heart Failure Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer Heart Failure Drugs Products Offered
12.2.5 Pfizer Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Corporation Information
12.3.2 AstraZeneca Description and Business Overview
12.3.3 AstraZeneca Heart Failure Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 AstraZeneca Heart Failure Drugs Products Offered
12.3.5 AstraZeneca Recent Development
12.4 Hikma
12.4.1 Hikma Corporation Information
12.4.2 Hikma Description and Business Overview
12.4.3 Hikma Heart Failure Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Hikma Heart Failure Drugs Products Offered
12.4.5 Hikma Recent Development
12.5 Teva
12.5.1 Teva Corporation Information
12.5.2 Teva Description and Business Overview
12.5.3 Teva Heart Failure Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Teva Heart Failure Drugs Products Offered
12.5.5 Teva Recent Development
12.6 Cipla
12.6.1 Cipla Corporation Information
12.6.2 Cipla Description and Business Overview
12.6.3 Cipla Heart Failure Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Cipla Heart Failure Drugs Products Offered
12.6.5 Cipla Recent Development
12.7 Merck & Co.
12.7.1 Merck & Co. Corporation Information
12.7.2 Merck & Co. Description and Business Overview
12.7.3 Merck & Co. Heart Failure Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Merck & Co. Heart Failure Drugs Products Offered
12.7.5 Merck & Co. Recent Development
12.8 Amgen
12.8.1 Amgen Corporation Information
12.8.2 Amgen Description and Business Overview
12.8.3 Amgen Heart Failure Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Amgen Heart Failure Drugs Products Offered
12.8.5 Amgen Recent Development
12.9 Roche
12.9.1 Roche Corporation Information
12.9.2 Roche Description and Business Overview
12.9.3 Roche Heart Failure Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Roche Heart Failure Drugs Products Offered
12.9.5 Roche Recent Development
12.10 Sun Pharma
12.10.1 Sun Pharma Corporation Information
12.10.2 Sun Pharma Description and Business Overview
12.10.3 Sun Pharma Heart Failure Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Sun Pharma Heart Failure Drugs Products Offered
12.10.5 Sun Pharma Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Description and Business Overview
12.11.3 Novartis Heart Failure Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Novartis Heart Failure Drugs Products Offered
12.11.5 Novartis Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Heart Failure Drugs Industry Trends
13.2 Heart Failure Drugs Market Drivers
13.3 Heart Failure Drugs Market Challenges
13.4 Heart Failure Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Heart Failure Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Heart Failure Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of ACEI
Table 3. Major Manufacturers of Angiotensin II Receptor Blockers
Table 4. Major Manufacturers of ARNIs
Table 5. Major Manufacturers of Beta Blockers
Table 6. Major Manufacturers of Aldosterone Antagonists
Table 7. Major Manufacturers of Diuretics
Table 8. Global Heart Failure Drugs Market Size Growth Rate by Application (2021-2027) & (MT)
Table 9. Global Heart Failure Drugs Market Size by Region (MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 10. Global Heart Failure Drugs Sales by Regions (2016-2021) & (MT)
Table 11. Global Heart Failure Drugs Sales Market Share by Regions (2016-2021)
Table 12. Global Heart Failure Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 13. Global Heart Failure Drugs Sales Forecast by Region (2022-2027) & (MT)
Table 14. Global Heart Failure Drugs Sales Market Share Forecast by Region (2022-2027)
Table 15. Global Heart Failure Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 16. Global Heart Failure Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 17. Global Heart Failure Drugs Sales by Manufacturers (2016-2021) (MT)
Table 18. Global Heart Failure Drugs Sales Share by Manufacturers (2016-2021)
Table 19. Ranking of Global Top Heart Failure Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 20. Heart Failure Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 21. Heart Failure Drugs Revenue Share by Manufacturers (2016-2021)
Table 22. Global Heart Failure Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 23. Global Heart Failure Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heart Failure Drugs as of 2020)
Table 24. Key Manufacturers Heart Failure Drugs Price (2016-2021) (USD/MT)
Table 25. Heart Failure Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Heart Failure Drugs Product Type
Table 27. Date of International Manufacturers Enter into Heart Failure Drugs Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Heart Failure Drugs Sales by Type (2016-2021) (MT)
Table 30. Global Heart Failure Drugs Sales Share by Type (2016-2021)
Table 31. Global Heart Failure Drugs Revenue by Type (2016-2021) (US$ Million)
Table 32. Global Heart Failure Drugs Revenue Share by Type (2016-2021)
Table 33. Heart Failure Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
Table 34. Global Heart Failure Drugs Sales Forecast by Type (2022-2027) & (MT)
Table 35. Global Heart Failure Drugs Sales Market Share Forecast by Type (2022-2027)
Table 36. Global Heart Failure Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 37. Global Heart Failure Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 38. Global Heart Failure Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
Table 39. Global Heart Failure Drugs Sales by Application (2016-2021) (MT)
Table 40. Global Heart Failure Drugs Sales Share by Application (2016-2021)
Table 41. Global Heart Failure Drugs Revenue by Application (2016-2021) (US$ Million)
Table 42. Global Heart Failure Drugs Revenue Share by Application (2016-2021)
Table 43. Heart Failure Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
Table 44. Global Heart Failure Drugs Sales Forecast by Application (2022-2027) & (MT)
Table 45. Global Heart Failure Drugs Sales Market Share Forecast by Application (2022-2027)
Table 46. Global Heart Failure Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 47. Global Heart Failure Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 48. Global Heart Failure Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
Table 49. United States Heart Failure Drugs Sales (MT) of Key Companies (2016-2021)
Table 50. United States Heart Failure Drugs Sales Share by Company (2016-2021)
Table 51. United States Heart Failure Drugs Revenue (US$ Million) by Company (2016-2021)
Table 52. United States Heart Failure Drugs Revenue Share by Company (2016-2021)
Table 53. United States Heart Failure Drugs Sales (MT) by Type (2016-2021)
Table 54. United States Heart Failure Drugs Sales Share by Type (2016-2021)
Table 55. United States Heart Failure Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 56. United States Heart Failure Drugs Price (USD/MT) by Type (2016-2021)
Table 57. United States Heart Failure Drugs Sales (MT) by Type (2022-2027)
Table 58. United States Heart Failure Drugs Sales Share by Type (2022-2027)
Table 59. United States Heart Failure Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 60. United States Heart Failure Drugs Revenue Share by Type (2022-2027)
Table 61. United States Heart Failure Drugs Price (USD/MT) by Type (2022-2027)
Table 62. United States Heart Failure Drugs Sales (MT) by Application (2016-2021)
Table 63. United States Heart Failure Drugs Sales Share by Application (2016-2021)
Table 64. United States Heart Failure Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 65. United States Heart Failure Drugs Price (USD/MT) by Application (2016-2021)
Table 66. United States Heart Failure Drugs Sales (MT) by Application (2022-2027)
Table 67. United States Heart Failure Drugs Sales Share by Application (2022-2027)
Table 68. United States Heart Failure Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 69. United States Heart Failure Drugs Revenue Share by Application (2022-2027)
Table 70. United States Heart Failure Drugs Price (USD/MT) by Application (2022-2027)
Table 71. North America Heart Failure Drugs Sales by Country (2016-2021) & (MT)
Table 72. North America Heart Failure Drugs Sales Market Share by Country (2016-2021)
Table 73. North America Heart Failure Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 74. North America Heart Failure Drugs Revenue Market Share by Country (2016-2021)
Table 75. Asia Pacific Heart Failure Drugs Sales by Region (2016-2021) & (MT)
Table 76. Asia Pacific Heart Failure Drugs Sales Market Share by Region (2016-2021)
Table 77. Asia Pacific Heart Failure Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 78. Asia Pacific Heart Failure Drugs Revenue Market Share by Region (2016-2021)
Table 79. Europe Heart Failure Drugs Sales by Country (2016-2021) & (MT)
Table 80. Europe Heart Failure Drugs Sales Market Share by Country (2016-2021)
Table 81. Europe Heart Failure Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 82. Europe Heart Failure Drugs Revenue Market Share by Country (2016-2021)
Table 83. Latin America Heart Failure Drugs Sales by Country (2016-2021) & (MT)
Table 84. Latin America Heart Failure Drugs Sales Market Share by Country (2016-2021)
Table 85. Latin Americaa Heart Failure Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 86. Latin America Heart Failure Drugs Revenue Market Share by Country (2016-2021)
Table 87. Middle East and Africa Heart Failure Drugs Sales by Country (2016-2021) & (MT)
Table 88. Middle East and Africa Heart Failure Drugs Sales Market Share by Country (2016-2021)
Table 89. Middle East and Africa Heart Failure Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 90. Middle East and Africa Heart Failure Drugs Revenue Market Share by Country (2016-2021)
Table 91. Novartis Corporation Information
Table 92. Novartis Description and Business Overview
Table 93. Novartis Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 94. Novartis Heart Failure Drugs Product
Table 95. Novartis Recent Development
Table 96. Pfizer Corporation Information
Table 97. Pfizer Description and Business Overview
Table 98. Pfizer Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 99. Pfizer Product
Table 100. Pfizer Recent Development
Table 101. AstraZeneca Corporation Information
Table 102. AstraZeneca Description and Business Overview
Table 103. AstraZeneca Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 104. AstraZeneca Product
Table 105. AstraZeneca Recent Development
Table 106. Hikma Corporation Information
Table 107. Hikma Description and Business Overview
Table 108. Hikma Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 109. Hikma Product
Table 110. Hikma Recent Development
Table 111. Teva Corporation Information
Table 112. Teva Description and Business Overview
Table 113. Teva Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 114. Teva Product
Table 115. Teva Recent Development
Table 116. Cipla Corporation Information
Table 117. Cipla Description and Business Overview
Table 118. Cipla Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 119. Cipla Product
Table 120. Cipla Recent Development
Table 121. Merck & Co. Corporation Information
Table 122. Merck & Co. Description and Business Overview
Table 123. Merck & Co. Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 124. Merck & Co. Product
Table 125. Merck & Co. Recent Development
Table 126. Amgen Corporation Information
Table 127. Amgen Description and Business Overview
Table 128. Amgen Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 129. Amgen Product
Table 130. Amgen Recent Development
Table 131. Roche Corporation Information
Table 132. Roche Description and Business Overview
Table 133. Roche Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 134. Roche Product
Table 135. Roche Recent Development
Table 136. Sun Pharma Corporation Information
Table 137. Sun Pharma Description and Business Overview
Table 138. Sun Pharma Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 139. Sun Pharma Product
Table 140. Sun Pharma Recent Development
Table 141. Mylan Corporation Information
Table 142. Mylan Description and Business Overview
Table 143. Mylan Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 144. Mylan Product
Table 145. Mylan Recent Development
Table 146. Heart Failure Drugs Market Trends
Table 147. Heart Failure Drugs Market Drivers
Table 148. Heart Failure Drugs Market Challenges
Table 149. Heart Failure Drugs Market Restraints
Table 150. Heart Failure Drugs Customers List
Table 151. Heart Failure Drugs Distributors List
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Heart Failure Drugs Product Picture
Figure 2. Global Heart Failure Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. ACEI Product Picture
Figure 4. Angiotensin II Receptor Blockers Product Picture
Figure 5. ARNIs Product Picture
Figure 6. Beta Blockers Product Picture
Figure 7. Aldosterone Antagonists Product Picture
Figure 8. Diuretics Product Picture
Figure 9. Global Heart Failure Drugs Sales Market Share by Application in 2020 & 2027
Figure 10. Reduced Ejection Fraction
Figure 11. Preserved Ejection Fraction
Figure 12. Heart Failure Drugs Report Years Considered
Figure 13. Global Heart Failure Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Heart Failure Drugs Market Size 2016-2027 (US$ Million)
Figure 15. Global Heart Failure Drugs Sales 2016-2027 (MT)
Figure 16. Global Heart Failure Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 17. Global Heart Failure Drugs Sales Market Share by Region (2016-2021)
Figure 18. Global Heart Failure Drugs Sales Market Share by Region in 2020
Figure 19. Global Heart Failure Drugs Revenue Market Share by Region (2016-2021)
Figure 20. Global Heart Failure Drugs Revenue Market Share by Region in 2020
Figure 21. Global Heart Failure Drugs Sales Share by Manufacturer in 2020
Figure 22. The Top 10 and 5 Players Market Share by Heart Failure Drugs Revenue in 2020
Figure 23. Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 24. Global Heart Failure Drugs Sales Market Share by Type (2016-2021)
Figure 25. Global Heart Failure Drugs Sales Market Share by Type in 2020
Figure 26. Global Heart Failure Drugs Revenue Market Share by Type (2016-2021)
Figure 27. Global Heart Failure Drugs Revenue Market Share by Type in 2020
Figure 28. Global Heart Failure Drugs Sales Market Share by Application (2016-2021)
Figure 29. Global Heart Failure Drugs Sales Market Share by Application in 2020
Figure 30. Global Heart Failure Drugs Revenue Market Share by Application (2016-2021)
Figure 31. Global Heart Failure Drugs Revenue Market Share by Application in 2020
Figure 32. United States Heart Failure Drugs Sales Growth Rate 2016-2027 (MT)
Figure 33. United States Heart Failure Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 34. United States Heart Failure Drugs Market Share in Global Market 2016-2027
Figure 35. United States 5 and 10 Largest Heart Failure Drugs Players Market Share by Revenue in Heart Failure Drugs in 2020
Figure 36. United States Heart Failure Drugs Revenue Share by Type (2016-2021)
Figure 37. United States Heart Failure Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 38. United States Heart Failure Drugs Revenue Share by Application (2016-2021)
Figure 39. United States Heart Failure Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 40. North America Heart Failure Drugs Sales Growth Rate 2016-2021 (MT)
Figure 41. North America Heart Failure Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 42. North America Heart Failure Drugs Sales Market Share by Country in 2020
Figure 43. North America Heart Failure Drugs Revenue Market Share by Country in 2020
Figure 44. U.S. Heart Failure Drugs Sales Growth Rate (2016-2021) (MT)
Figure 45. U.S. Heart Failure Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Canada Heart Failure Drugs Sales Growth Rate (2016-2021) (MT)
Figure 47. Canada Heart Failure Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Europe Heart Failure Drugs Sales Growth Rate 2016-2021 (MT)
Figure 49. Europe Heart Failure Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 50. Europe Heart Failure Drugs Sales Market Share by Country in 2020
Figure 51. Europe Heart Failure Drugs Revenue Market Share by Country in 2020
Figure 52. Germany Heart Failure Drugs Sales Growth Rate (2016-2021) (MT)
Figure 53. Germany Heart Failure Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. France Heart Failure Drugs Sales Growth Rate (2016-2021) (MT)
Figure 55. France Heart Failure Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. U.K. Heart Failure Drugs Sales Growth Rate (2016-2021) (MT)
Figure 57. U.K. Heart Failure Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Italy Heart Failure Drugs Sales Growth Rate (2016-2021) (MT)
Figure 59. Italy Heart Failure Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Russia Heart Failure Drugs Sales Growth Rate (2016-2021) (MT)
Figure 61. Russia Heart Failure Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Asia Pacific Heart Failure Drugs Sales Growth Rate 2016-2021 (MT)
Figure 63. Asia Pacific Heart Failure Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 64. Asia Pacific Heart Failure Drugs Sales Market Share by Region in 2020
Figure 65. Asia Pacific Heart Failure Drugs Revenue Market Share by Region in 2020
Figure 66. China Heart Failure Drugs Sales Growth Rate (2016-2021) (MT)
Figure 67. China Heart Failure Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. Japan Heart Failure Drugs Sales Growth Rate (2016-2021) (MT)
Figure 69. Japan Heart Failure Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. South Korea Heart Failure Drugs Sales Growth Rate (2016-2021) (MT)
Figure 71. South Korea Heart Failure Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. India Heart Failure Drugs Sales Growth Rate (2016-2021) (MT)
Figure 73. India Heart Failure Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Australia Heart Failure Drugs Sales Growth Rate (2016-2021) (MT)
Figure 75. Australia Heart Failure Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Taiwan Heart Failure Drugs Sales Growth Rate (2016-2021) (MT)
Figure 77. Taiwan Heart Failure Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Indonesia Heart Failure Drugs Sales Growth Rate (2016-2021) (MT)
Figure 79. Indonesia Heart Failure Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Thailand Heart Failure Drugs Sales Growth Rate (2016-2021) (MT)
Figure 81. Thailand Heart Failure Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Malaysia Heart Failure Drugs Sales Growth Rate (2016-2021) (MT)
Figure 83. Malaysia Heart Failure Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Philippines Heart Failure Drugs Sales Growth Rate (2016-2021) (MT)
Figure 85. Philippines Heart Failure Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Vietnam Heart Failure Drugs Sales Growth Rate (2016-2021) (MT)
Figure 87. Vietnam Heart Failure Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Latin America Heart Failure Drugs Sales Growth Rate 2016-2021 (MT)
Figure 89. Latin America Heart Failure Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 90. Latin America Heart Failure Drugs Sales Market Share by Country in 2020
Figure 91. Latin America Heart Failure Drugs Revenue Market Share by Country in 2020
Figure 92. Mexico Heart Failure Drugs Sales Growth Rate (2016-2021) (MT)
Figure 93. Mexico Heart Failure Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Brazil Heart Failure Drugs Sales Growth Rate (2016-2021) (MT)
Figure 95. Brazil Heart Failure Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Argentina Heart Failure Drugs Sales Growth Rate (2016-2021) (MT)
Figure 97. Argentina Heart Failure Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. Middle East and Africa Heart Failure Drugs Sales Growth Rate 2016-2021 (MT)
Figure 99. Middle East and Africa Heart Failure Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 100. Middle East and Africa Heart Failure Drugs Sales Market Share by Country in 2020
Figure 101. Middle East and Africa Heart Failure Drugs Revenue Market Share by Country in 2020
Figure 102. Turkey Heart Failure Dr

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Digoxin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 75

According to our LPI (LP Information) latest study, the global Digoxin market size was valued at US$ 59 million in 2023. With growing demand in downstream market, the Digoxin is forecast to a readjusted size of US$ 73 million by 2030 with a CAGR of 3.2% during review period. The research report highlights the growth potential of the global Digoxin market. Digoxin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain op......

Global Heart Failure Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Heart Failure Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Heart Failure Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Heart Failure Drugs market. Heart Failure Drugs are expected to show stable growth in the future market. However, product differentiatio......

Global Atorvastatin Calcium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 138

According to our LPI (LP Information) latest study, the global Atorvastatin Calcium market size was valued at US$ 214.2 million in 2023. With growing demand in downstream market, the Atorvastatin Calcium is forecast to a readjusted size of US$ 362 million by 2030 with a CAGR of 7.8% during review period. The research report highlights the growth potential of the global Atorvastatin Calcium market. Atorvastatin Calcium are expected to show stable growth in the future market. However, prod......

Global Rosuvastatin Calcium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 139

According to our LPI (LP Information) latest study, the global Rosuvastatin Calcium market size was valued at US$ 514.3 million in 2023. With growing demand in downstream market, the Rosuvastatin Calcium is forecast to a readjusted size of US$ 683.6 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Rosuvastatin Calcium market. Rosuvastatin Calcium are expected to show stable growth in the future market. However, pr......

Global Atorvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 133

According to our (Global Info Research) latest study, the global Atorvastatin Calcium market size was valued at USD 225.3 million in 2023 and is forecast to a readjusted size of USD 366.1 million by 2030 with a CAGR of 7.2% during review period. Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL choleste......

Global Rosuvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 132

According to our (Global Info Research) latest study, the global Rosuvastatin Calcium market size was valued at USD 540.9 million in 2023 and is forecast to a readjusted size of USD 703.6 million by 2030 with a CAGR of 3.8% during review period. Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart att......

Cilostazol - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 118

The global Cilostazol market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cilostazol in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Cilostazol market. Injection Cilostazol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-dried P......

Rosuvastatin - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 110

Rosuvastatin medication is a statin that is used to lower bad cholesterol and prevent cardiovascular disease. It works by blocking an enzyme in the liver that makes cholesterol. It is taken by mouth and should be used together with dietary changes, exercise, and weight loss. It may also raise good cholesterol and lower triglycerides. It is sold under the brand name Crestor among others. It may be used when other statins have not worked well. The global Rosuvastatin market size is expected......

Global Congestive Heart Failure Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Congestive Heart Failure Drugs market: According to our latest research, the global Congestive Heart Failure Drugs market looks promising in the next 5 years. As of 2022, the global Congestive Heart Failure Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Congestive heart failure is a serious and complex condition in which the heart muscles are either dam......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs